These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21188841)

  • 21. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--a "ratologist" point of view.
    Julien C
    J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188799
    [No Abstract]   [Full Text] [Related]  

  • 22. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Cohn JN
    J Appl Physiol (1985); 2010 Dec; 109(6):2006-7. PubMed ID: 21188834
    [No Abstract]   [Full Text] [Related]  

  • 23. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.
    Kobori H; Fu Q; Crowley SD; Gonzalez-Villalobos RA; Campos RR
    J Appl Physiol (1985); 2010 Dec; 109(6):2003. PubMed ID: 21148352
    [No Abstract]   [Full Text] [Related]  

  • 24. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Intrarenal angiotensin II generation as a hypertensinogenic mechanism.
    Gonzalez-Villalobos RA; Fuchs S
    J Appl Physiol (1985); 2010 Dec; 109(6):2013. PubMed ID: 21188829
    [No Abstract]   [Full Text] [Related]  

  • 25. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. AT1 receptors in the kidney mediate the chronic hypertensive response to angiotensin II.
    Crowley SD
    J Appl Physiol (1985); 2010 Dec; 109(6):2012-3. PubMed ID: 21188828
    [No Abstract]   [Full Text] [Related]  

  • 26. Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.
    Navar LG
    J Appl Physiol (1985); 2010 Dec; 109(6):1998-2000; discussion 2015. PubMed ID: 21148349
    [No Abstract]   [Full Text] [Related]  

  • 27. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):1996-8; discussion 2016. PubMed ID: 20185633
    [No Abstract]   [Full Text] [Related]  

  • 28. Rebuttal from Esler, Lambert, and Schlaich.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):2000-1. PubMed ID: 21148350
    [No Abstract]   [Full Text] [Related]  

  • 29. Rebuttal from Navar.
    Navar LG
    J Appl Physiol (1985); 2010 Dec; 109(6):2001-2. PubMed ID: 21148351
    [No Abstract]   [Full Text] [Related]  

  • 30. The sympathetic nervous system and hypertension: recent developments.
    DiBona GF
    Hypertension; 2004 Feb; 43(2):147-50. PubMed ID: 14707153
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.
    Chen W; Leo S; Weng C; Yang X; Wu Y; Tang X
    Herz; 2015 Apr; 40 Suppl 2():190-6. PubMed ID: 24609799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation.
    Lohmeier TE; Iliescu R
    J Appl Physiol (1985); 2012 Nov; 113(10):1652-8. PubMed ID: 22797307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sympathetic nervous system and blood pressure in humans: implications for hypertension.
    Fisher JP; Paton JF
    J Hum Hypertens; 2012 Aug; 26(8):463-75. PubMed ID: 21734720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early renal denervation prevents development of hypertension in growth-restricted offspring.
    Ojeda NB; Johnson WR; Dwyer TM; Alexander BT
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1212-6. PubMed ID: 17880379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
    Lincevicius GS; Shimoura CG; Nishi EE; Perry JC; Casarini DE; Gomes GN; Bergamaschi CT; Campos RR
    Am J Hypertens; 2015 Sep; 28(9):1083-90. PubMed ID: 25628418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a critical role of the sympathetic nervous system in hypertension.
    Grassi G; Ram VS
    J Am Soc Hypertens; 2016 May; 10(5):457-66. PubMed ID: 27052349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between the sympathetic nervous system and angiotensin system in renovascular hypertension.
    Pradhan N; Rossi NF
    Curr Hypertens Rev; 2013 May; 9(2):121-9. PubMed ID: 23971694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the renin-angiotensin system, renal sympathetic nerve system, and oxidative stress in chronic foot shock-induced hypertension in rats.
    Dong T; Chen JW; Tian LL; Wang LH; Jiang RD; Zhang Z; Xu JB; Zhao XD; Zhu W; Wang GQ; Sun WP; Zhang GX
    Int J Biol Sci; 2015; 11(6):652-63. PubMed ID: 25999788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired baroreflex sensitivity and responses to angiotensin converting enzyme inhibitor in salt-induced hypertension and its prevention by dietary calcium supplement in Sprague-Dawley rats.
    Ladipo CO; Egbe PE; Ibu JO
    Afr J Med Med Sci; 2006 Mar; 35(1):29-36. PubMed ID: 17209324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sympathetic Activation in Hypertension: Importance of the Central Nervous System.
    Hirooka Y
    Am J Hypertens; 2020 Oct; 33(10):914-926. PubMed ID: 32374869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.